Shang-Wen Lin

Dr. Shang-Wen Lin specializes in the development of advanced drug delivery systems, with a particular focus on nanomedicine and immunotherapy for localized and controlled therapeutic applications. Her research has explored a wide range of innovative platforms, including the design of nanostructured lipid carriers (NLCs) for the topical delivery of a nalbuphine prodrug to alleviate pruritus. She has also investigated the use of extracellular vesicles as carriers for immune checkpoint inhibitors in glioma immunotherapy. In addition to her core research, Dr. Lin has extended the application of NLC-based systems to areas such as wound healing and inhalable anti-inflammatory treatments. Her multidisciplinary background bridges pharmaceutical sciences, drug delivery, and nanotechnology, contributing to a growing body of translational research aimed at addressing unmet clinical needs.